Renal Graft Function After Treatment With Erythropoietin (EPO)

Summary

Background : Numerous studies have outlined the cellular pleiotropic effects of erythropoietin (EPO) and their role in the prevention of ischemic-reperfusion lesion such as after acute ischemic injury of the brain or the heart. However, most of these studies were carried out in animal models and no definitive proof exists today to demonstrate that EPO has similar beneficial effects in human pathology. Purpose : The aim of the study is to demonstrate that in humans, EPO can protect against ischemic-reperfusion lesions in a model of ischemia i.e. kidney transplantation.

Timeline

Start

2011-12

Primary completion

2013-03

Completion

2013-03

Outcome

Outcome not reported

Stopped: “Lack of patients eligible for the study.”

Drugs

Indications